CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 409 filers reported holding CRISPR THERAPEUTICS AG in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,893 | -91.9% | 174 | -90.0% | 0.00% | -94.1% |
| Q2 2023 | $97,887 | -3.5% | 1,744 | -22.3% | 0.02% | -5.6% |
| Q1 2023 | $101,469 | -14.3% | 2,244 | -23.0% | 0.02% | -18.2% |
| Q4 2022 | $118,451 | -46.4% | 2,914 | -13.8% | 0.02% | -50.0% |
| Q3 2022 | $221,000 | -2.6% | 3,379 | -9.6% | 0.04% | +2.3% |
| Q2 2022 | $227,000 | -50.3% | 3,739 | -48.6% | 0.04% | -41.9% |
| Q1 2022 | $457,000 | -0.2% | 7,274 | -2.5% | 0.07% | -2.6% |
| Q4 2021 | $458,000 | -42.2% | 7,464 | +5.3% | 0.08% | -43.7% |
| Q3 2021 | $793,000 | +16.3% | 7,087 | +68.2% | 0.14% | +12.5% |
| Q2 2021 | $682,000 | +83.8% | 4,214 | +38.3% | 0.12% | +69.0% |
| Q1 2021 | $371,000 | – | 3,047 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $32,581,000 | 55.55% |
| NEA Management Company, LLC | 1,590,002 | $103,907,000 | 5.19% |
| ARK Investment Management | 8,237,122 | $538,296,000 | 3.75% |
| Nikko Asset Management Americas, Inc. | 4,262,736 | $277,078,000 | 3.54% |
| CLOUGH CAPITAL PARTNERS L P | 414,767 | $27,105,000 | 2.89% |
| Integral Health Asset Management, LLC | 220,000 | $14,377,000 | 2.79% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,268,000 | 2.48% |
| HC Advisors, LLC | 53,944 | $3,525,000 | 2.43% |
| Green Alpha Advisors, LLC | 27,466 | $1,795,000 | 1.52% |
| EFG Asset Management (North America) Corp. | 84,356 | $5,516,000 | 1.28% |